Gilead Sciences Inc (GILD)
Total asset turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 28,749,000 | 28,295,000 | 27,800,000 | 27,450,000 | 27,116,000 | 27,390,000 | 27,382,000 | 27,043,000 | 27,281,000 | 27,136,000 | 27,515,000 | 27,472,000 | 27,305,000 | 27,482,000 | 26,638,000 | 25,564,000 | 24,689,000 | 23,147,000 | 22,174,000 | 22,716,000 |
| Total assets | US$ in thousands | 58,995,000 | 54,525,000 | 53,579,000 | 56,292,000 | 62,125,000 | 62,373,000 | 62,337,000 | 61,876,000 | 63,171,000 | 62,557,000 | 62,870,000 | 63,080,000 | 67,952,000 | 67,098,000 | 67,984,000 | 67,492,000 | 68,407,000 | 60,878,000 | 55,934,000 | 59,741,000 |
| Total asset turnover | 0.49 | 0.52 | 0.52 | 0.49 | 0.44 | 0.44 | 0.44 | 0.44 | 0.43 | 0.43 | 0.44 | 0.44 | 0.40 | 0.41 | 0.39 | 0.38 | 0.36 | 0.38 | 0.40 | 0.38 |
December 31, 2024 calculation
Total asset turnover = Revenue (ttm) ÷ Total assets
= $28,749,000K ÷ $58,995,000K
= 0.49
Total asset turnover is a financial ratio that measures a company's efficiency in generating sales revenue from its total assets. For Gilead Sciences Inc, the total asset turnover ratio has fluctuated over the periods provided.
From March 31, 2020, to December 31, 2021, the ratio ranged from 0.36 to 0.41, indicating that the company was generating approximately $0.36 to $0.41 in revenue for every dollar of assets it owned.
Subsequently, from March 31, 2022, to December 31, 2024, the total asset turnover ratio improved, reaching a range between 0.43 to 0.52. This increase suggests that Gilead Sciences Inc became more efficient in utilizing its assets to generate sales revenue during these periods.
Overall, the trend indicates an improvement in the company's ability to generate sales from its assets over time, with the ratio gradually increasing towards the end of the period. This implies that Gilead Sciences Inc was able to enhance its operations and effectiveness in utilizing its assets to drive revenue growth.
Peer comparison
Dec 31, 2024